196 related articles for article (PubMed ID: 136326)
1. Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency.
Held H; Enderle C
Clin Nephrol; 1976 Sep; 6(3):388-93. PubMed ID: 136326
[TBL] [Abstract][Full Text] [Related]
2. The binding of chloramphenicol to serum proteins in patients with chronic renal insufficiency.
Grafnetterová J; Vodrázka Z; Jandová D; Schück O; Tomásek R; Lachmanová J
Clin Nephrol; 1976 Oct; 6(4):448-50. PubMed ID: 975643
[TBL] [Abstract][Full Text] [Related]
3. [Interactions of phenylbutazone and oxyphenbutazone with glymidine (author's transl)].
Held M; Scheible G
Arzneimittelforschung; 1981; 31(6):1036-8. PubMed ID: 6455124
[TBL] [Abstract][Full Text] [Related]
4. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
Terawaki H; Nakayama K; Matsuyama Y; Nakayama M; Sato T; Hosoya T; Era S; Ito S
Blood Purif; 2007; 25(3):274-9. PubMed ID: 17460395
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Effects of renal failure on blood levels of cimetidine.
Ma KW; Brown DC; Masler DS; Silvis SE
Gastroenterology; 1978 Feb; 74(2 Pt 2):473-7. PubMed ID: 620915
[TBL] [Abstract][Full Text] [Related]
7. [Elimination half-life and serum protein binding of the anti-rheumatism agent naproxen in kidney failure].
Held H
Z Rheumatol; 1979; 38(3-4):111-9. PubMed ID: 442840
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic uremic patients with protein-poor diet and oral supply of essential amino acids. II. Clinical results of long-term treatment.
Norée LO; Bergström J
Clin Nephrol; 1975; 3(5):195-203. PubMed ID: 1149344
[TBL] [Abstract][Full Text] [Related]
9. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
[TBL] [Abstract][Full Text] [Related]
10. Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases.
Tiula E; Tallgren LG; Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):545-52. PubMed ID: 3429058
[TBL] [Abstract][Full Text] [Related]
11. Assay of serum abnormalities in uremic and dialysis patients. Evidence for depletion of vital substances in hemodialysis.
Quadracci LJ; Cambi V; Christopher TG; Harker LA; Striker GE
Trans Am Soc Artif Intern Organs; 1971; 17():96-101. PubMed ID: 5158140
[No Abstract] [Full Text] [Related]
12. Studies of the elevated extracellular concentration of cyclic AMP in uremic man.
Hamet P; Stouder DA; Ginn HE; Hardman JG; Liddle GW
J Clin Invest; 1975 Aug; 56(2):339-45. PubMed ID: 168232
[TBL] [Abstract][Full Text] [Related]
13. Plasma protein binding of zolpidem in liver and renal insufficiency.
Pacifici GM; Viani A; Rizzo G; Carrai M; Ganansia J; Bianchetti G; Morselli PL
Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):439-43. PubMed ID: 3198298
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
15. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
[TBL] [Abstract][Full Text] [Related]
16. [Protein binding of various cephems in healthy subjects and patients with chronic renal failure].
Kuroyama M; Kumano K; Tomonaga F; Sakai T; Mashimo S
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):769-77. PubMed ID: 1770637
[TBL] [Abstract][Full Text] [Related]
17. Protein in the diets of dialyzed and non-dialyzed uremic patients. Study with nitrogen-labeled urea.
Smith EB; Hill PA
J Am Diet Assoc; 1972 May; 60(5):389-93. PubMed ID: 5018368
[No Abstract] [Full Text] [Related]
18. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
Caravaca F; Arrobas M; Luna E; Naranjo M; Pizarro JL; Sánchez-Casado E
Nefrologia; 2002; 22(5):432-7. PubMed ID: 12497744
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting serum and urinary guanidinosuccinic acid levels in normal and uremic subjects.
Kopple JD; Gordon SI; Wang M; Swendseid ME
J Lab Clin Med; 1977 Aug; 90(2):303-11. PubMed ID: 886215
[TBL] [Abstract][Full Text] [Related]
20. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
